Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs16986825 | chr22:29300306 | C/T | 1.32E-5 | 174 | 25.77 | 24.03 | 28.6 | KM Plot |
PCPG | rs16991288 | chr22:44384881 | G/C | 8.94E-5 | 175 | 24.6 | 27.47 | 19.87 | KM Plot |
PCPG | rs17002510 | chr22:42002957 | A/G | 0.000232 | 178 | NA | 20.37 | 26.57 | KM Plot |
PCPG | rs17007164 | chr2:61452502 | A/G | 6.95E-5 | 177 | 23.43 | 30.93 | 10.3 | KM Plot |
PCPG | rs17007356 | chr2:61465504 | A/C | 2.72E-5 | 178 | 23.15 | 30.18 | 23.77 | KM Plot |
PCPG | rs17008097 | chr2:61523070 | C/G | 0.000486 | 178 | 21.95 | 30.63 | 17.85 | KM Plot |
PCPG | rs17008217 | chr2:61537167 | G/C | 6.43E-5 | 178 | 23.43 | 29.88 | 10.3 | KM Plot |
PCPG | rs17039811 | chr2:61540478 | T/C | 6.95E-5 | 177 | 23.43 | 29.43 | 10.3 | KM Plot |
PCPG | rs17047421 | chr2:118555719 | T/A | 1.89E-5 | 176 | 25.17 | 25.97 | 11.65 | KM Plot |
PCPG | rs17047429 | chr2:118557083 | T/C | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs17047434 | chr2:118558995 | G/T | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs17047438 | chr2:118569406 | C/T | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs17047457 | chr2:118583249 | G/A | 1.92E-5 | 176 | 25.17 | 25.97 | 11.65 | KM Plot |
PCPG | rs17047460 | chr2:118584741 | T/C | 1.92E-5 | 176 | 25.17 | 25.97 | 11.65 | KM Plot |
PCPG | rs17047593 | chr2:118723032 | T/C | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |